THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Master Manufacturing Services Agreement August 21,...Master Manufacturing Services Agreement • September 14th, 2018 • Osmotica Pharmaceuticals PLC • Pharmaceutical preparations • New York
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration {the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
EX-10.3 4 reph-ex103_327.htm EX-10.3 Execution VersionMaster Manufacturing Services Agreement • May 5th, 2020 • England
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED. CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD BE LIKELY TO CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. REDACTED MATERIAL IS MARKED...Master Manufacturing Services Agreement • May 23rd, 2023 • Indivior PLC • Pharmaceutical preparations • Delaware
EX-10.60 3 dex1060.htm MASTER MANUFACTURING AGREEMENT BETWEEN MITEL AND FLEXTRONICS TELECOM SYSTEMS MITEL NETWORKS CORPORATION - AND - FLEXTRONICS TELECOM SYSTEMS, LTD MASTER MANUFACTURING SERVICES AGREEMENT * Confidential treatment has been requested...Master Manufacturing Services Agreement • May 5th, 2020 • New York
This Master Manufacturing Services Agreement (“Agreement”) is entered into as of the 1st day of May, 2007 ( the “Effective Date”) by and between Mitel Networks Corporation having its place of business at 350 Legget Drive, Ottawa, Ontario, K2K 2W7, Canada (“Customer”) and Flextronics Telecom Systems, Ltd., having its place of business at Level 3, Alexander House, 35 Cybercity, Ebene, Mauritius (“Flextronics”).
AMENDMENT NO. 1 TO MASTER MANUFACTURING SERVICES AGREEMENTMaster Manufacturing Services Agreement • September 14th, 2018 • Osmotica Pharmaceuticals PLC • Pharmaceutical preparations • New York
This Amendment No. 1 to the Master Manufacturing Services Agreement (this “Amendment”) effective January 1, 2017 (the “Amendment Effective Date”), between Osmotica Pharmaceutical US LLC, a Delaware limited liability company, having its principal place of business at 895 Sawyer Road, Marietta, Georgia 30062 (“Client”) and Patheon Pharmaceuticals Inc. a Delaware corporation having its principal place of business at 2110 East Galbraith Road, Cincinnati, OH 45237-1625 (“Patheon”), and together with Client, the “Parties”, and each, a “Party”).
Master Manufacturing Services Agreement August 3, 2015Master Manufacturing Services Agreement • February 28th, 2024 • Acadia Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each Party), and intending to be legally bound the Parties agree as follows:
MASTER MANUFACTURING SERVICES AGREEMENTMaster Manufacturing Services Agreement • August 24th, 2018 • Versartis, Inc. • Pharmaceutical preparations • New York
THIS MASTER MANUFACTURING SERVICES AGREEMENT (this “Agreement”) is entered into as of July 11, 2016 (the “Effective Date”), by and between WUXI BIOLOGICS (HONG KONG) LIMITED having a principal place of business at 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China 200131 (“CMO”), and ARAVIVE BIOLOGICS, INC., having a principal place of business at 909 Fannin, Suite 2100, Houston, Texas 77010 (“Client”). CMO and Client are sometimes referred to herein individually as a “Party” and collectively as “Parties.”
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Triple asterisks denote omission. Master Manufacturing...Master Manufacturing Services Agreement • March 1st, 2022 • Akebia Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
Master Manufacturing Services Agreement 14 JUNE 2017Master Manufacturing Services Agreement • March 8th, 2021 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
Master Manufacturing Services Agreement May 21, 2013Master Manufacturing Services Agreement • June 28th, 2017 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound, the parties agree as follows:
EX-10.59 2 dex1059.htm MASTER MANUFACTURING SERVICES AGREEMENT BETWEEN MITEL AND ITS SUBSIDIARIES MASTER MANUFACTURING SERVICES AGREEMENT * Confidential treatment has been requested and a complete copy of this agreement has been filed with the...Master Manufacturing Services Agreement • May 5th, 2020 • Ontario
This Master Manufacturing Services Agreement (“Agreement”) is entered into as of the 20th day of June, 2008 ( the “Effective Date”) by and between Mitel Networks Corporation having its place of business at 350 Legget Drive, Ottawa, Ontario, K2K 2W7, Canada , on its own behalf and on behalf of its Affiliates, (“Customer”) and BreconRidge Corporation, having its place of business at 500 Palladium Drive, Ottawa, Ontario, K2V 1C2 Canada , on its own behalf and on behalf of its Affiliates, (“BreconRidge”).
In the event that any Product shall not be in conformity with the foregoing warranties, [***].Master Manufacturing Services Agreement • August 10th, 2009 • Trimble Navigation LTD /Ca/ • Measuring & controlling devices, nec
The following provisions shall be in addition to and not by way of limitation of any other rights or obligations that Trimble may have upon termination of this Agreement:
MASTER MANUFACTURING SERVICES AGREEMENTMaster Manufacturing Services Agreement • March 29th, 2023 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • New York
This Master Manufacturing Services Agreement (the "Agreement") is made as of June 3, 2016 (the "Effective Date"), between LONZA HOUSTON, INC., a Delaware corporation having its principal place of business at 8066 El Rio St., Houston, TX 77054 ("LONZA"), and bluebird bio., Inc., a Delaware corporation having an office at 150 Second Street, Third Floor, Cambridge, MA 02141 on behalf of itself and its Affiliates ("CLIENT") (each of LONZA and CLIENT, a "Party" and, collectively, the "Parties").
Master Manufacturing Services AgreementMaster Manufacturing Services Agreement • October 22nd, 2019 • Baudax Bio, Inc. • Services-misc health & allied services, nec • England
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
ContractMaster Manufacturing Services Agreement • August 8th, 2019 • Savara Inc • Pharmaceutical preparations • Delaware
Certain identified information in this document has been excluded because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. [***] indicates where such information has been omitted.
Master Manufacturing Services Agreement July 28, 2017Master Manufacturing Services Agreement • August 2nd, 2017 • Paratek Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each Party), and intending to be legally bound the Parties agree as follows:
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. INFORMATION THAT WAS OMITTED HAS BEEN NOTED IN THIS DOCUMENT WITH A PLACEHOLDER...Master Manufacturing Services Agreement • April 24th, 2024 • Calliditas Therapeutics AB • Pharmaceutical preparations
With effect from the date stated at the start of this Agreement (the “Effective Date”), the parties have agreed to the following terms:
Master Manufacturing Services Agreement October 1, 2015Master Manufacturing Services Agreement • February 23rd, 2016 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations • New York
[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Master Manufacturing Services Agreement 1st July, 2016Master Manufacturing Services Agreement • March 14th, 2018 • Melinta Therapeutics, Inc. /New/ • Pharmaceutical preparations • England
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
Master Manufacturing Services AgreementMaster Manufacturing Services Agreement • August 7th, 2019 • Cara Therapeutics, Inc. • Pharmaceutical preparations • New York
With effect from the date stated at the start of this Agreement (the “Effective Date”), the Parties have agreed to the following terms:
Master Manufacturing Services Agreement October 31, 2013Master Manufacturing Services Agreement • May 23rd, 2014 • Horizon Pharma, Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
Master Manufacturing Services AgreementMaster Manufacturing Services Agreement • February 29th, 2016 • TESARO, Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
Master Manufacturing Services Agreement October 31, 2013Master Manufacturing Services Agreement • March 13th, 2014 • Horizon Pharma, Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
Master Manufacturing Services Agreement 28 November 2016Master Manufacturing Services Agreement • April 25th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • England
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
Master Manufacturing Services Agreement August 3, 2015Master Manufacturing Services Agreement • November 5th, 2015 • Acadia Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each Party), and intending to be legally bound the Parties agree as follows:
Master Manufacturing Services Agreement October 1, 2015Master Manufacturing Services Agreement • February 23rd, 2021 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations • New York
In consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
MASTER MANUFACTURING SERVICES AGREEMENTMaster Manufacturing Services Agreement • November 6th, 2020 • AYRO, Inc. • Communications services, nec • Delaware
This Master Manufacturing Services Agreement (“Agreement”) is effective as of September 25, 2020 (the “Effective Date”) by and between Karma Automotive LLC having an address of 9950 Jeronimo Road, Irvine, California 92618 (“Company”), and AYRO, Inc. having an address of 900 E. Old Settlers Boulevard, Suite 100, Round Rock, Texas 78664 (“Customer”). Customer and Company are each sometimes referred to herein as a “Party” and collectively as the “Parties.”
RECITALSMaster Manufacturing Services Agreement • April 4th, 2002 • Pri Automation Inc • Special industry machinery, nec • Massachusetts
Master Manufacturing Services Agreement July 28, 2017Master Manufacturing Services Agreement • November 6th, 2017 • Paratek Pharmaceuticals, Inc. • Pharmaceutical preparations • England
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each Party), and intending to be legally bound the Parties agree as follows:
AMENDMENT TO MASTER MANUFACTURING SERVICES AGREEMENTMaster Manufacturing Services Agreement • March 29th, 2023 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances)
This Amendment ("Amendment") is made and entered into as of October 23, 2017 (the "Amendment Effective Date") to that certain Master Manufacturing Services Agreement dated June 3, 2016 (including all amendments, modifications and supplements thereto, the "Agreement") by and between bluebird bio, Inc., a Delaware corporation having an office at 60 Binney Street, Cambridge, MA 02142 on behalf of itself and its Affiliates ("Client"); and Lonza Houston, Inc., a Delaware corporation having its principal place of business at 8066 El Rio St., Houston, TX 77054 ("Lonza"). The parties identified above are sometimes hereinafter individually referred to as a "Party" and collectively as the "Parties".
Master Manufacturing Services AgreementMaster Manufacturing Services Agreement • August 18th, 2021 • Galera Therapeutics, Inc. • Pharmaceutical preparations • Delaware
With effect from the date stated at the start of this Agreement (the “Effective Date”), the parties have agreed to the following terms:
Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder...Master Manufacturing Services Agreement • November 26th, 2021 • Amylyx Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Master Manufacturing Services Agreement March 18, 2020Master Manufacturing Services Agreement • August 10th, 2020 • ChemoCentryx, Inc. • Pharmaceutical preparations • New York
Patheon’s liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement [for any Product] in a Year will not exceed, in the aggregate, the maximum credit value set forth below:
Master Manufacturing Services Agreement October 15, 2018Master Manufacturing Services Agreement • March 1st, 2022 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • New York
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
SECOND AMENDMENT TO MASTER MANUFACTURING SERVICES AGREEMENTMaster Manufacturing Services Agreement • November 7th, 2023 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances)
This Second Amendment (the “Second Amendment”) is made and entered into effective as of the last date of signature below (the “Second Amendment Effective Date”) and amends that certain Master Manufacturing Services Agreement dated June 3, 2016, as previously amended by the first Amendment dated October 23, 2017, (the “Agreement”), by and between Lonza Houston, Inc., a Delaware corporation having its principal place of business at 14905 Kirby Drive, Houston, TX 77047 (“LONZA”), and bluebird bio, Inc., a Delaware corporation having an office at 455 Grand Union Blvd, Somerville, MA 02145, on behalf of itself and its Affiliates (“CLIENT”) (each of LONZA and CLIENT, a “Party” and, collectively, the “Parties”).
